Article | May 11, 2017

Iceland Manufacturer Builds Facility Designed for Drug Cost Savings

By Bruce Blau

Iceland Manufacturer Builds Facility Designed for Drug Cost Savings

In June 2016, Alvotech opened their new biosimilar manufacturing facility in Reykjavik, Iceland, using best of breed solutions from leading Life Science vendors.  The key directive for Alvotech was to create a flexible, agile process which could adapt and be used for any conceivable process.  The result:  A high yield disposable fermentation and downstream process, with a fill-and-finish line for vials and prefilled syringes, tied together with a complete, end-to-end upstream/downstream automation and Manufacturing Execution System.